Cognis Half-Year Results: Strong Growth in Sales and Earnings
Furthermore, the company announces that the process of reviewing the strategic options for Cognis has now been completed: The shareholders decided to continue their investment for the next couple of years.
The Strategic Business Units (SBUs) Care Chemicals, Nutrition & Health, Functional Products, and Process Chemicals all posted sales that exceeded the 2005 figures, while Oleochemicals' sales remained stable. All regions contributed to this positive development. The growth in the company's Adjusted EBITDA reflects this improvement in sales, and also the fact that despite increased raw material and energy costs, the company has been able to reduce its overall costs by further improving operational efficiency. Adjusted for the effects of currency fluctuations, sales increased by 4.5 percent and Adjusted EBITDA by 5.5 percent.
Comments Antonio Trius, CEO of Cognis, "We are satisfied with the business's development over the first six months. Our innovative product offering and branded ingredients have made a particular contribution to achieving this result." To learn more about the company, visit www.cognis.com/.